CAGNACCI, Angelo
 Distribuzione geografica
Continente #
NA - Nord America 29.224
EU - Europa 17.508
AS - Asia 4.637
SA - Sud America 30
Continente sconosciuto - Info sul continente non disponibili 25
AF - Africa 13
OC - Oceania 6
Totale 51.443
Nazione #
US - Stati Uniti d'America 29.179
GB - Regno Unito 7.547
CN - Cina 2.350
IT - Italia 2.120
DE - Germania 2.074
SE - Svezia 1.847
UA - Ucraina 1.765
HK - Hong Kong 1.187
FI - Finlandia 897
TR - Turchia 839
BG - Bulgaria 650
FR - Francia 206
RU - Federazione Russa 139
IN - India 86
IE - Irlanda 61
IR - Iran 45
KR - Corea 40
PL - Polonia 36
CA - Canada 35
ES - Italia 33
NL - Olanda 33
EU - Europa 24
VN - Vietnam 24
BE - Belgio 22
MY - Malesia 21
BR - Brasile 17
CH - Svizzera 16
PT - Portogallo 14
CL - Cile 12
DK - Danimarca 10
JP - Giappone 10
IL - Israele 8
MX - Messico 7
GR - Grecia 6
ID - Indonesia 6
LY - Libia 5
AU - Australia 4
BY - Bielorussia 4
CZ - Repubblica Ceca 4
PH - Filippine 4
RO - Romania 4
AT - Austria 3
HU - Ungheria 3
SG - Singapore 3
AE - Emirati Arabi Uniti 2
BZ - Belize 2
EG - Egitto 2
HR - Croazia 2
KZ - Kazakistan 2
MC - Monaco 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
RS - Serbia 2
SM - San Marino 2
TW - Taiwan 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BH - Bahrain 1
CR - Costa Rica 1
DZ - Algeria 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MD - Moldavia 1
ME - Montenegro 1
MT - Malta 1
NG - Nigeria 1
NO - Norvegia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 51.443
Città #
Southend 7.074
Jacksonville 4.026
Fairfield 3.613
Dearborn 2.598
Woodbridge 2.279
Chandler 2.083
Houston 1.729
Ashburn 1.653
Wilmington 1.442
Ann Arbor 1.232
Seattle 1.205
Hong Kong 1.183
Cambridge 1.149
Nyköping 1.120
Beijing 1.033
Princeton 757
Sofia 650
Eugene 640
Modena 604
Izmir 425
Bremen 423
San Diego 369
Helsinki 260
New York 187
Des Moines 185
Milan 129
Norwalk 105
Hefei 91
London 90
Kunming 77
Nanjing 75
Shanghai 65
Dublin 61
Rome 61
San Mateo 50
Boardman 43
Falls Church 43
Redwood City 41
Guangzhou 38
Verona 38
Dongguan 35
Jinan 34
Nanchang 33
Grafing 32
Augusta 30
Kraków 30
Bologna 27
Dong Ket 22
Saint Petersburg 21
Hebei 20
Hounslow 19
Kilburn 19
Ardabil 18
Brussels 18
Fuzhou 18
Mountain View 18
Shenyang 18
Monmouth Junction 17
Philadelphia 16
Chiswick 15
Leawood 15
Orsogna 15
Turin 15
Xian 15
Dallas 14
Catania 13
Palermo 13
Florence 12
San Francisco 12
Toronto 12
Andover 11
Prescot 11
Solignano Nuovo 11
Torino 11
Tulare 11
Washington 11
Baotou 10
Borås 10
Chicago 10
Genoa 10
Mumbai 10
Bari 9
Chongqing 9
Hanover 9
Indiana 9
Islington 9
Parma 9
San Jose 9
Southwark 9
Zhengzhou 9
Aosta 8
Cornigliano 8
Padova 8
Pune 8
Aabenraa 7
Cagliari 7
Ceranova 7
Gwangju 7
Kish 7
Madrid 7
Totale 39.793
Nome #
Differenza tra forma attiva (5-MTHF) e inattiva (acido folico) di folati sulla vasodilatazione di donne in postmenopausa 237
La melatonina aumenta la risposta delle gonadotropine al GnRH nelle donne in fase follicolare precoce, ma non nella fase luteale 235
Recommendations for contraception in women with diabetes. AMD-SIC position paper 204
The Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive Life 193
Are climacteric complaints associated with risk factors of cardiovascular disease in peri-menopausal women? 192
Intermenstrual pelvic pain, quality of life and mood 190
Prediction of age at menopause from assessment of ovarian reserve may be improved by using body mass index and smoking status. 184
Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History 180
The ovarian response to controlled stimulation in IVF cycles may be predictive of the age at menopause 180
Adenomyosis of the Extrapelvic Portion of the Round Ligament 177
Intensity of menstrual pain and estimated angle of uterine flexion 176
Metabolic impact of combined hormonal contraceptives containing estradiol 175
Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes 175
Folate administration decreases oxidative status and blood pressure in postmenopausal women 174
Impact of laparoscopic cystectomy of endometriotic and non-endometriotic cysts on ovarian volume, antral follicle count (AFC) and ovarian doppler velocimetry 173
Efficacia del nomegestrolo acetato, derivato del 19-Nor progesterone, nel trattamento dei sintomi premestruali: uso in casi selezionati con fase luteale inadeguata 166
Medical and patient attitude towards vaginal atrophy: the AGATA study 165
Influence of an oral contraceptive containing drospirenone on insulin sensitivity of healthy women 165
Reproductive risk factors in women with family history of breast cancer attending an Italian Family Cancer Clinic 164
Prospective measurement of blood pressure and heart rate over 24 h in women using combined oral contraceptives with estradiol 164
High-dose short-term folate administration modifies ambulatory blood pressure in postmenopausal women. A placebo-controlled study. 163
Body composition and resting metabolic rate of perimenopausal women using continuous progestogen contraception 161
Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men. 160
Pharmacokinetic evaluation of desogestrel as a female contraceptive 160
Relation between oxidative stress and climacteric symptoms in early postmenopausal women 159
Association between urinary incontinence and climacteric symptoms in postmenopausal women 158
Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study 157
Menopause, estrogens, progestins, or their combination on body weight and anthropometric measures. 155
Relation between body mass index and endothelium-dependent vasodilatation in healthy postmenopausal women. 153
Cyclic progestin administration increases energy expenditure and decreases body fat mass in perimenopausal women 153
Pelvic Pain and Quality of Life of Women With Endometriosis During Quadriphasic Estradiol Valerate/Dienogest Oral Contraceptive. A Patient-Preference Prospective 24-Week Pilot Study 153
Seasonal trend of acute pelvic inflammatory disease 152
Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea 152
Role of melatonin in circadian rhythm at menopause 151
Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial 148
Altered neuroendocrine regulation of luteinizing hormone secretion in postmenopausal women with Parkinson's disease. 148
“In patient” medical abortion versus surgical abortion: patient’s satisfaction 147
Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey 147
Prevalence of menstrual pain in young women: what is dysmenorrhea 146
Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized study. 146
Age at Menopause and Extent of Coronary Artery Disease Among Postmenopausal Women with Acute Coronary Syndromes 145
Modification of 24-h ambulatory blood pressure and heart rate during contraception with the vaginal ring: a prospective study. 144
Progestin suppressed inflammation and cell viability of tumor necrosis factor-α-stimulated endometriotic stromal cells 144
Amplification of pulsatile LH secretion by exogenous melatonin in women 144
Amplification of pulsatile LH secretion by exogenous melatonin in women. 143
Physiological doses of estradiol decrease nocturnal blood pressure in normotensive postmenopausal women. 143
Administration of tibolone decreases 24h heart rate but not blood pressure of post-menopausal women 142
Acute modifications in the levels of daytime melatonin do not influence leptin in postmenopausal women 142
Modification of blood pressure in postmenopausal women: role of hormone replacement therapy 142
Melatonin in relation to physiology in adult humans 141
Effects of hormone replacement therapy on C-reactive protein levels in healthy postmenopausal women: Comparison between oral and transdermal administration of estrogen 141
Dienogest mediates midkine suppression in endometriosis 141
Effect of Estradiol valerate plus dienogest on body composition of healthy women in the menopausal transition: A prospective one-year evaluation 140
Influence of melatonin and photoperiod on animal and human reproduction 139
Administration of raloxifene does not influence 24-hour ambulatory blood pressure of postmenopausal women with osteopenia: a double-blind placebo-controlled study. 139
Inflammation influences steroid hormone receptors targeted by progestins in endometrial stromal cells from women with endometriosis 139
Prolonged melatonin administration decreases nocturnal blood pressure in women 138
Modification of body composition and metabolism during oral contraceptives containing non-androgenic progestins in association with estradiol or ethinyl estradiol 138
European society of contraception statement on contraception in obese women 138
Counseling on vaginal delivery of contraceptive hormones: implications for women's body knowledge and sexual health 138
Menopausal symptoms and risk factors for cardiovascular disease in postmenopause. 138
Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the Italian VVA study group* 134
Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study 133
Combined oral contraceptive containing drospirenone does not modify 24-h ambulatory blood pressure but increases heart rate in healthy young women: prospective study 131
Effect of prolonged administration of transdermal estradiol on flow-mediated endothelium-dependent and endothelium-independent vasodilation in healthy postmenopausal women. 131
The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation 131
Regulation of the 24-hour rhythm of body temperature in menstrual cycles with spontaneous and gonadotropin-induced ovulation. 130
Oral contraceptives and bone metabolism. 129
Does dienogest influence the inflammatory response of endometriotic cells? A systematic review 129
Biometrical threshold of biparietal diameter for certain fetal sex assignment by ultrasound. 128
Lack of any estrogenic effect of ipriflavone in postmenopausal women. 126
Oral contraceptives and insulin sensitivity 126
Vaginal atrophy of women in postmenopause. Results from amulticentric observational study: The AGATA study 125
The chronic administration of cabergoline normalizes androgen secretion and improves menstrual cyclicity in women with polycystic ovary syndrome. 125
Sympathoadrenal response of postmenopausal women prior and during prolonged administration of estradiol 125
Prevalence and association between objective signs and subjective symptoms of vaginal atrophy: the AGATA study 124
Melatonin enhances cortisol levels in aged women: reversible by estrogens. 123
Melatonin: a major regulator of the circadian rhythm of core temperature in humans. 123
ISPOG European Consensus Statement - chronic pelvic pain in women (short version) 123
Relation of folates, vitamin B12 and homocysteine to vertebral bone mineral density change in postmenopausal women. A five-year longitudinal evaluation. 123
Effect of naloxone on body temperature in postmenopausal women with Parkinson's disease. 122
The effect of menopause on blood lipid and lipoprotein levels 122
A role for melatonin in PCOS? 121
Anello Contraccettivo: i vantaggi della somministrazione vaginale 121
Effects of progestins on estrogen-induced increase in C-reactive protein in postmenopausal women 121
Influence of transdermal estradiol in the regulation of leptin levels of postmenopausal women: A double-blind, placebo-controlled study 121
Treatment with flutamide improves hyperinsulinemia in women with idiopathic hirsutism. 120
Melatonin in aged women. Possible modulation by estrogens. 120
Hypothermic effect of melatonin and nocturnal core body temperature decline are reduced in aged women. 119
Tibolone and estradiol plus norethisterone acetate similarly influence endothelium-dependent vasodilatation in healthy postmenopausal women 118
Endothelin-1 and nitric oxide levels are related to cardiovascular risk factors but are not modified by estradiol replacement in healthy postmenopausal women. A cross-sectional and a randomized cross-over study 118
Relation of homocysteine, folate, and vitamin B12 to bone mineral density of postmenopausal women 117
Modulation of anterior pituitary luteinizing hormone response to gonadotropin-releasing hormone by insulin-like growth factor I in vitro. 117
Oral contraceptives and vascular reactivity of great vessels in women. 116
Indirect evidence that estrogen replacement therapy stimulates nitric oxide synthase in postmenopausal women 116
Course of primary headaches during hormone replacement therapy. 116
Potentially beneficial cardiovascular effects of melatonin administration in women. 116
Reply to: Comment on 'Season of birth influences the timing of menopause' [7] 116
A comparison of the central effects of different progestins used in hormone replacement therapy 116
Levonorgestrel administration in emergency contraception: bleeding pattern and pituitary-ovarian function 115
Totale 14.484
Categoria #
all - tutte 176.720
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 176.720


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193.128 0 0 0 0 0 0 0 0 0 457 1.405 1.266
2019/202012.000 866 985 269 564 1.463 2.051 2.153 867 1.044 359 909 470
2020/20217.786 1.066 188 699 655 926 334 966 1.038 257 1.005 356 296
2021/20226.963 130 1.273 483 459 142 334 250 390 941 573 704 1.284
2022/20236.690 972 573 365 449 1.184 1.018 125 616 891 60 225 212
2023/20244.084 201 264 198 332 1.266 515 622 569 74 43 0 0
Totale 51.994